We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+16.02%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$3.09B
AUM Growth
+$972M
Cap. Flow
+$684M
Cap. Flow %
22.14%
Top 10 Hldgs %
6.41%
Holding
2,561
New
545
Increased
906
Reduced
750
Closed
342

Top Buys

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$27.9M
2
HUM icon
Humana
HUM
+$18.6M
3
CMS icon
CMS Energy
CMS
+$17.6M
4
BMY icon
Bristol-Myers Squibb
BMY
+$15M
5
AJG icon
Arthur J. Gallagher & Co
AJG
+$13.5M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$92M
2
MSFT icon
Microsoft
MSFT
+$10.4M
3
RTX icon
RTX Corp
RTX
+$10.3M
4
SNPS icon
Synopsys
SNPS
+$10.3M
5
WY icon
Weyerhaeuser
WY
+$9.46M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.11%
2 Technology 15.39%
3 Healthcare 12.56%
4 Financials 10.75%
5 Industrials 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NITE
2201
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$7K ﹤0.01%
288
-5,344
-95% -$94.5K
VRDN icon
2202
Viridian Therapeutics
VRDN
$2.49B
$6K ﹤0.01%
133
-34
-20% -$1.54K
SRRA
2203
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$6K ﹤0.01%
89
-67
-43% -$4.3K
MDCO
2204
DELISTED
Medicines Co
MDCO
$6K ﹤0.01%
+200
New +$4.71K
WRB icon
2205
W.R. Berkley
WRB
$26.8B
$5K ﹤0.01%
+189
New +$4.46K
PVLA
2206
Palvella Therapeutics
PVLA
$2.23B
$5K ﹤0.01%
19
-133
-88% -$31.6K
GPN icon
2207
Global Payments
GPN
$24B
$3K ﹤0.01%
20
-2,130
-99% -$259K
TTOO
2208
DELISTED
T2 Biosystems, Inc
TTOO
– –
0
– –
CNSL
2209
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$2K ﹤0.01%
200
-26,259
-99% -$275K
PGNX
2210
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$2K ﹤0.01%
526
-6,369
-92% -$28.8K
LILAK icon
2211
Liberty Latin America Class C
LILAK
$1.72B
$1K ﹤0.01%
89
-62,004
-100% -$966K
TELL
2212
DELISTED
Tellurian Inc.
TELL
$1K ﹤0.01%
+97
New +$912
PRVB
2213
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$1K ﹤0.01%
500
-950
-66% -$2.23K
ABEO icon
2214
Abeona Therapeutics
ABEO
$393M
– –
-1,935
Closed -$345K
ABR icon
2215
Arbor Realty Trust
ABR
$957M
– –
-127,062
Closed -$1.28M
ADAP
2216
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-15,233
Closed -$88K
ADVM
2217
DELISTED
Adverum Biotechnologies
ADVM
– –
-2,784
Closed -$88K
AEIS icon
2218
Advanced Energy
AEIS
$13B
– –
-11,056
Closed -$475K
AG icon
2219
First Majestic Silver
AG
$8.52B
– –
-26,404
Closed -$156K
AGCO icon
2220
AGCO
AGCO
$7.12B
– –
-23,474
Closed -$1.31M
AGIO icon
2221
Agios Pharmaceuticals
AGIO
$1.91B
– –
-19,626
Closed -$905K
ALLE icon
2222
Allegion
ALLE
$14.3B
– –
-15,200
Closed -$1.21M
ALNY icon
2223
Alnylam Pharmaceuticals
ALNY
$28.9B
– –
-30,178
Closed -$2.2M
AMKR icon
2224
Amkor Technology
AMKR
$13.5B
– –
-30,858
Closed -$202K
AMPH icon
2225
Amphastar Pharmaceuticals
AMPH
$873M
– –
-12,105
Closed -$241K
87 88
89
90 91

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q1 2019 Portfolio in Review

As of Q1 2019, Cubist Systematic Strategies held 2,561 positions worth $3.09B, up 46% from $2.12B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

Cubist Systematic Strategies deployed $684M of net new capital in Q1 2019, opening 545 new positions and adding to 906 existing holdings. Its largest new stake was Arthur J. Gallagher & Co: 175,587 shares worth $13.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $92M trimmed.

  • Cubist Systematic Strategies's largest Q1 2019 buy was Arthur J. Gallagher & Co: 175,587 shares worth $13.7M.
  • Cubist Systematic Strategies added most to ConocoPhillips in Q1 2019, an estimated $27.9M increase.
  • Cubist Systematic Strategies's biggest Q1 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $92M.
  • Cubist Systematic Strategies fully exited Nasdaq in Q1 2019, selling an estimated $6.35M.
  • Cubist Systematic Strategies's ten largest holdings make up 6.4% of its $3.09B portfolio in Q1 2019.
  • Cubist Systematic Strategies opened 545 new positions and closed 342 in Q1 2019.
  • Cubist Systematic Strategies's portfolio value rose 46% quarter-over-quarter to $3.09B.

Based on Cubist Systematic Strategies's 13F filing for Q1 2019, filed 15 May 2019.